Synthesis of novel molecular probes inspired by harringtonolide.
暂无分享,去创建一个
R. Quinn | D. Camp | M. Campitelli | V. Hegde
[1] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[2] W. Lusby,et al. Harringtonolide, a plant growth inhibitory tropone from Cephalotaxus harringtonia (Forbes) K. Koch , 1978 .
[3] U. Sanyal,et al. A novel synthesis of a tricyclo (7.5.01,5.01,9) tetradecane ring system related to gascardic acid. , 1978 .
[4] B. E. Evans,et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.
[5] Barbara Frey,et al. The development of more efficient syntheses of polycyclic diterpenes through intramolecular cyclopropanation of aryl rings in diazomethyl ketones , 1996 .
[6] M. Lautens,et al. Transition Metal-Mediated Cycloaddition Reactions. , 1996, Chemical reviews.
[7] W. Guida,et al. The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.
[8] Abraham Nudelman,et al. NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities. , 1997, The Journal of organic chemistry.
[9] Barbara Frey,et al. Synthesis of the Unusual Diterpenoid Tropones Hainanolidol and Harringtonolide , 1998 .
[10] Barbara Frey,et al. Total Synthesis of the Pentacyclic Diterpenoid Tropone Hainanolidol , 2000 .
[11] D. Kingston. Recent Advances in the Chemistry of Taxol1,2 , 2000 .
[12] M. Leopoldo,et al. A multireceptorial binding reinvestigation on an extended class of σ ligands: N-[ω-(indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards σ1 and EBP sites , 2001 .
[13] S. Hinuma,et al. Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists. , 2002, Journal of medicinal chemistry.
[14] David R Spring,et al. Diversity-oriented synthesis; a challenge for synthetic chemists. , 2003, Organic & biomolecular chemistry.
[15] John Steele,et al. Drug-like properties: guiding principles for design - or chemical prejudice? , 2004, Drug discovery today. Technologies.
[16] R. Desimone,et al. Privileged structures: applications in drug discovery. , 2004, Combinatorial chemistry & high throughput screening.
[17] W. Dehaen,et al. A microwave-assisted click chemistry synthesis of 1,4-disubstituted 1,2,3-triazoles via a copper(I)-catalyzed three-component reaction. , 2004, Organic letters.
[18] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[19] L. Dubost,et al. Utility of a chiral 1,3-dioxane template in stereoselective intramolecular Diels–Alder reactions , 2007 .
[20] L. Mander,et al. Model studies toward the synthesis of the bioactive diterpenoid, harringtonolide. , 2007, Organic & biomolecular chemistry.
[21] Anang A Shelat,et al. Scaffold composition and biological relevance of screening libraries. , 2007, Nature chemical biology.
[22] J. Cortes,et al. Homoharringtonine for the treatment of chronic myelogenous leukemia , 2008, Expert opinion on pharmacotherapy.
[23] George Nikolakopoulos,et al. Synthesis of four novel natural product inspired scaffolds for drug discovery. , 2009, The Journal of organic chemistry.
[24] Jason E Hein,et al. Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides. , 2010, Chemical Society reviews.
[25] Matthew E Welsch,et al. Privileged scaffolds for library design and drug discovery. , 2010, Current opinion in chemical biology.
[26] W. Marsden. I and J , 2012 .
[27] E. Eisenhauer,et al. The Taxoids , 2012, Drugs.
[28] Aaas News,et al. Book Reviews , 1893, Buffalo Medical and Surgical Journal.